By Marc Jones LONDON (Reuters) - The global stock's rally got back on track on Tuesday, with more support from the Federal Reserve and the Bank of Japan helping to end a bumpy few days for financial markets. A near 5% jump by Japan's Nikkei had given Asia its best day...
LONDON (Reuters) - Giving low doses of the generic steroid drug dexamethasone to patients admitted to hospital with COVID-19 reduced death rates by around a third among those with the most severe cases of infection, trial data showed on Tuesday. The results, described as a "major breakthrough" by scientists leading...
JAKARTA (Reuters) - Hundreds of children in Indonesia are believed to have died from COVID-19, giving the Southeast Asian country one of the world’s highest rates of child deaths from the novel coronavirus that experts around the world say poses little danger to the young. Paediatricians and health officials in...
BANGKOK (Reuters) - Thailand will consider a plan to reopen more businesses and establishments from as early as June 15, an official said on Wednesday, after the country has reported no local transmissions of the coronavirus in the past 16 days. The government’s Centre for COVID-19 Situation Administration will consider...
(Reuters) Here’s what you need to know about the coronavirus right now: Most infectious at the start Studies show people with the coronavirus are most infectious just at the point when they first begin to feel unwell, World Health Organization (WHO) experts said on Tuesday. Dr. Mike Ryan, WHO’s top emergencies expert, said...
STOCKHOLM, June 3 (Reuters) - Volvo Cars, owned by China's Geely Holding, said on Wednesday it sold 40% more cars in May than in April, as restrictions to contain the spread of the COVID-19 pandemic started to ease in several markets. While still down 25.5% in May from a year...
BENGALURU, June 3 (Reuters) - India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients. Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials and is at the...
By P. Kandiah and Geetha Kandiah Moderna Inc., Sanofi, AstraZeneca plc, Roche, Gilead Sciences and Novartis are just some of the many pharmaceutical companies working to fast-track the development of a coronavirus vaccine. Many companies and research institutions from various countries are racing to develop the vaccine for COVID-19. Who...
BEIJING, May 29 (Reuters) - Global travel disruptions are the top concern for American businesses in China, of which many are cutting compensation and bonuses amid the fallout of the COVID-19 epidemic, according to a report from a business group. Ninety percent of the 100 or so respondents said they...
By Josh Horwitz SHANGHAI, May 22 (Reuters) - The latest U.S. government action against China's Huawei takes direct aim at the company's HiSilicon chip division -- a business that in a few short years has become central to China's ambitions in semiconductor technology but will now lose access to tools...